Search Results - Félicie Chaumont

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial

    Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial by Pannus, Pieter, Depickère, Stéphanie, Kemlin, Delphine, Houben, Sarah, Neven, Kristof Y, Heyndrickx, Leo, Michiels, Johan, Willems, Elisabeth, De Craeye, Stéphane, Francotte, Antoine, Chaumont, Félicie, Olislagers, Véronique, Waegemans, Alexandra, Verbrugghe, Mathieu, Schmickler, Marie-Noëlle, Van Gucht, Steven, Dierick, Katelijne, Marchant, Arnaud, Desombere, Isabelle, Ariën, Kevin K, Goossens, Maria E

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults

    Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults by Pannus, Pieter, Depickère, Stéphanie, Kemlin, Delphine, Georges, Daphnée, Houben, Sarah, Olislagers, Véronique, Waegemans, Alexandra, De Craeye, Stéphane, Francotte, Antoine, Chaumont, Félicie, Van Oostveldt, Celien, Heyndrickx, Leo, Michiels, Johan, Willems, Elisabeth, Dhondt, Emilie, Krauchuk, Marharyta, Schmickler, Marie-Noëlle, Verbrugghe, Mathieu, Van Loon, Nele, Dierick, Katelijne, Matagne, André, Desombere, Isabelle, Ariën, Kevin K., Marchant, Arnaud, Goossens, Maria E.

    Published in Vaccine
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial

    Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial by Pieter Pannus, Stéphanie Depickère, Delphine Kemlin, Sarah Houben, Kristof Y. Neven, Leo Heyndrickx, Johan Michiels, Elisabeth Willems, Stéphane De Craeye, Antoine Francotte, Félicie Chaumont, Véronique Olislagers, Alexandra Waegemans, Mathieu Verbrugghe, Marie-Noëlle Schmickler, Steven Van Gucht, Katelijne Dierick, Arnaud Marchant, Isabelle Desombere, Kevin K. Ariën, Maria E. Goossens

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: